NOT-NS-03-020: NINDS ANNOUNCES BUDGET CEILING INCREASE FOR CLINICAL RESEARCH ON SOLICITED SPECIALIZED RESEARCH CENTERS

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

NINDS ANNOUNCES BUDGET CEILING INCREASE FOR CLINICAL RESEARCH ON 
SOLICITED SPECIALIZED RESEARCH CENTERS 

RELEASE DATE:  July 3, 2003

NOTICE:  NOT-NS-03-020

National Institute of Neurological Disorders and Stroke (NINDS)
 (http://www.ninds.nih.gov)

PURPOSE

NINDS has released three initiatives in the last five years to create 
centers (P50 and U54 mechanisms) to perform translational and clinical 
research in Parkinson's disease 
(http://grants.nih.gov/grants/guide/pa-files/PAR-03-004.html), 
stroke (http://grants.nih.gov/grants/guide/pa-files/PAS-01-092.html),
and minority health 
(http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-00-001.html).  
Performance of high quality research involving patient-oriented research 
(http://www.nih.gov/news/crp/97report/execsum.htm) requires resources 
devoted to training personnel, ensuring appropriate inclusion and 
follow-up of subjects, monitoring patient safety, and coordinating 
activity among participating sites. In order to ensure that important 
patient-oriented projects proceed with adequate resources, NINDS 
announces that investigators submitting new applications for these 
programs may request annual direct costs up to $1,500,000.

Investigators with existing grants in these programs (NINDS MORRIS K. 
UDALL PARKINSON'S DISEASE RESEARCH CENTERS OF EXCELLENCE, NINDS 
SPECIALIZED PROGRAM OF TRANSLATIONAL RESEARCH IN ACUTE STROKE, and 
NINDS SPECIALIZED NEUROSCIENCE RESEARCH PROGRAMS AT MINORITY 
INSTITUTIONS) may submit competitive supplement applications for 
support of clinical projects that meet the NIH definition of patient-
oriented research. Total direct costs for these projects including the 
requested supplements, exclusive of indirect costs on subcontracts, may 
not exceed $1,500,000.  

Applications for supplements to existing grants within these listed 
programs must clearly state the relationship of the proposed clinical 
project to the goals of the original grant.  NINDS has specific review 
criteria for clinical studies and applicants are strongly urged to 
contact NINDS staff during preparation of a submission. Applicants 
should refer to NINDS guidelines for conduct of clinical trials or 
projects found at 
http://www.ninds.nih.gov/funding/research/clinical_research/index.htm

Future initiatives may be covered by the conditions of this 
announcement.

Direct programmatic inquiries to: 

Mary Ellen Michel, Ph.D.
Program Director, Repair and Plasticity
NINDS/NIH
NSC 2222, MSC 9525
6001 Executive Boulevard
Bethesda, MD 20892
Rockville, MD 20852 (courier only)
301-496-1447
Email: [email protected]

Direct inquiries about review to:

Katherine Woodbury-Harris, Ph.D.
Scientific Review Branch, NINDS
NSC 3208
6001 Executive Boulevard
Bethesda, MD 20892
Rockville, MD 20852 (courier only)
301-496-9223
[email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices